Substituted nucleosides, nucleotides and analogs thereof
US-2015366887-A1 · Dec 24, 2015 · US
Compositions including triciribine and taxanes and methods of use thereof
US9101641B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9101641-B2 |
| Application number | US-201314091073-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 26, 2013 |
| Priority date | Mar 29, 2004 |
| Publication date | Aug 11, 2015 |
| Grant date | Aug 11, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This application relates to combination therapies including triciribine and related compounds and taxanes and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for treating a subject having a tumor or cancer, which tumor or cancer overexpresses AKT kinase comprising: (i) determining whether the subject has a tumor or cancer that overexpresses AKT kinase; (ii) if said subject has a tumor or cancer that overexpresses AKT kinase, a. administering to said subject: i. 45 mg/m 2 or less of at least one compound of formula I selected from the group consisting of the following compounds:…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Physics · mapped topic
Physics · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9101641B2 cover?
- This application relates to combination therapies including triciribine and related compounds and taxanes and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.
- Who is the assignee on this patent?
- Univ South Florida
- What technology area does this patent fall under?
- Primary CPC classification A61K31/7064. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).